One of the most important parts during drug discovery process is toxicity screening, which is to generate information about a substance's toxic properties so that the health and environmental risks it poses can be adequately evaluated. Research on induced pluripotent stem cells (iPSCs) promises to enhance drug discovery and development by providing simple, reproducible, and economically effective tools for drug toxicity screening under development. BioCytoceuticals provides customers with comprehensive toxicology examining to meet the governing regulations for new drug.
hiPSC-derived hepatocytes show great promise because of their ability to have a primary tissue-like phenotype, unlimited availability, and potential to establish genotype-specific cells from different individuals. These reasons make iPSCs an exciting alternative in vitro model system.
The neurotoxicity test models will allow for studying on one hand the adverse effect on drug candidates and, on the other hand, the general neurotoxicity in test well suited for screening of lead compounds. We provide customers with efficient neurotoxicity testing service to support their scientific research.
BioCytoceuticals is an experienced and outstanding provider of toxicity testing service. We are dedicated to providing detailed data and comprehensive service for your scientific research, and we are pleased to use our extensive experience and advanced platform to offer the best service to satisfy each demand from our customers.
If you have any special need in toxicity testing, do not hesitate to contact us for this special service. Please let us know what you need and we will accommodate you. We are looking forward to working with you in the future.
Inquiry
